A biflavonoid‐rich extract from Selaginella moellendorffii Hieron. induces apoptosis via STAT3 and Akt/NF‐κB signalling pathways in laryngeal carcinoma

Selaginella moellendorffii Hieron. (SM), a perennial evergreen plant, has been used in the treatment of acute infectious hepatitis, thoracic and hypochondriac lumbar contusions, systemic oedema and thrombocytopaenia. However, the role of a biflavonoid‐rich extract from SM (SM‐BFRE) in anti‐larynx ca...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cellular and molecular medicine 2020-10, Vol.24 (20), p.11922-11935
Hauptverfasser:	Huang, Huiqi, Hao, Ji, Pang, Kejian, Lv, Yibing, Wan, Dingrong, Wu, Chaoqun, Ma, Yuanren, Yang, Xinzhou, Zhang, Wei K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acids AKT protein Akt/NF‐κB Animals Annexin V Apoptosis Apoptosis - drug effects Biflavonoids - chemistry Biflavonoids - pharmacology biflavonoid‐rich extract Cancer therapies Cell Biology Cell culture Cell Line, Tumor Cell migration Cell Movement - drug effects Cell proliferation Cell Proliferation - drug effects Chromatography Edema Female Hepatitis Humans Laryngeal cancer Laryngeal carcinoma Laryngeal Neoplasms - metabolism Laryngeal Neoplasms - pathology Larynx Life Sciences & Biomedicine Liquid chromatography Medicine, Research & Experimental Mice, Inbred BALB C Mice, Nude Mitochondria Models, Biological Morphology Natural products Neoplasm Transplantation NF-kappa B - metabolism NMR Nuclear magnetic resonance Original Penicillin Plant Extracts - chemistry Plant Extracts - pharmacology Proto-Oncogene Proteins c-akt - metabolism Research & Experimental Medicine Science & Technology Selaginella moellendorffii Selaginella moellendorffii Hieron Selaginellaceae - chemistry Signal transduction Signal Transduction - drug effects STAT3 Stat3 protein STAT3 Transcription Factor - metabolism Thorax Thrombocytopenia Wound healing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!